Ptc Therapeutics, Inc. · NASDAQ:PTCT
Armistice Capital, LLC reported a 8.27% stake in Ptc Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC reported a 8.27% stake in Ptc Therapeutics, Inc., 6,378,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 8.27%
- Shares
- 6,378,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 8.27% | 6,378,000 |
| Steven Boyd | 8.27% | 6,378,000 |
Source
Related
- Ptc Therapeutics, Inc.
- Armistice Capital, LLC
- Ptc Therapeutics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026